Cristina M. Oprean

Eftimie Murgu Sq. No.2
Timisoara, TM 300041, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Body Mass Index and Outcomes in HR+/HER2- Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study.

Body Mass Index and Outcomes in HR+/HER2- Metastatic Breast Cancer Treated with Palbociclib: Insights from a National Real-World Study.

Journal: Cancers

Published: April 14, 2026

Giant Malignant Phyllodes Tumor with Secondary Thyroid Involvement.

Giant Malignant Phyllodes Tumor with Secondary Thyroid Involvement.

Journal: Diseases (Basel, Switzerland)

Published: January 30, 2026

Romanian Consensus Statement for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer (HR+/HER2- mBC) and Triple-Negative Metastatic Breast Cancer (mTNBC).

Romanian Consensus Statement for Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer (HR+/HER2- mBC) and Triple-Negative Metastatic Breast Cancer (mTNBC).

Journal: Current oncology (Toronto, Ont.)

Published: December 14, 2025

The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review.

The Prognostic and Predictive Value of Body Mass Index in Patients with HR+/HER2- Breast Cancer Treated with CDK4/6 Inhibitors: A Systematic Literature Review.

Journal: Cancers

Published: December 01, 2025

Recurrence Patterns in Breast Cancer: A Single-Center Retrospective Analysis.

Recurrence Patterns in Breast Cancer: A Single-Center Retrospective Analysis.

Journal: Journal of clinical medicine

Published: September 16, 2025

Real-World, National Study of Palbociclib in HR+/HER2- Metastatic Breast Cancer: A 2.5-Year Follow-Up PALBO01/2021.

Real-World, National Study of Palbociclib in HR+/HER2- Metastatic Breast Cancer: A 2.5-Year Follow-Up PALBO01/2021.

Journal: Diagnostics (Basel, Switzerland)

Published: March 24, 2025

Risk factors for breast cancer recurrence in postmenopausal women: a bibliometric study.

Risk factors for breast cancer recurrence in postmenopausal women: a bibliometric study.

Journal: Frontiers in oncology

Published: November 04, 2024

Pregnancy in a Young Patient with Metastatic HER2-Positive Breast Cancer-Between Fear of Recurrence and Desire to Procreate.

Pregnancy in a Young Patient with Metastatic HER2-Positive Breast Cancer-Between Fear of Recurrence and Desire to Procreate.

Journal: Current oncology (Toronto, Ont.)

Published: April 14, 2023

Perception of disease, dyadic coping, and the quality of life of oncology patients in the active treatment phase and their life partners: an approach based on the actor-partner interdependence model.

Perception of disease, dyadic coping, and the quality of life of oncology patients in the active treatment phase and their life partners: an approach based on the actor-partner interdependence model.

Journal: Frontiers in psychology

Published: October 14, 2022

Attitudes towards COVID‑19 vaccination in patients with cancer: A cross‑sectional study of 12 oncology centers.

Attitudes towards COVID‑19 vaccination in patients with cancer: A cross‑sectional study of 12 oncology centers.

Journal: Molecular and clinical oncology

Published: August 02, 2022

Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients.

Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients.

Journal: International journal of environmental research and public health

Published: February 03, 2022

Management of HER2-Positive Breast Cancer for a Young Patient with Visceral Crisis-The Adjuvant Role of Lifestyle Changes.

Management of HER2-Positive Breast Cancer for a Young Patient with Visceral Crisis-The Adjuvant Role of Lifestyle Changes.

Journal: Current oncology (Toronto, Ont.)

Published: January 21, 2022

Showing 1-12 of 27

Last Updated: 09/26/2026